Diagnostic and therapeutic approaches for elderly asthma patients: the importance of multidisciplinary and multidimensional management
暂无分享,去创建一个
[1] T. Soma,et al. Immunosenescence, Inflammaging, and Lung Senescence in Asthma in the Elderly , 2022, Biomolecules.
[2] Benoni Roberto,et al. Clinical response to biologics for severe asthma: any relevance for sex in different age ranges? , 2022, ERJ Open Research.
[3] A. Didier,et al. Self-reported asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey. , 2021, Respiratory medicine and research.
[4] N. Ghani,et al. Multi-Dimensional Assessment and Interdisciplinary Care to Reduce Asthma Readmissions in Safety Net Hospitals , 2021, Respiratory Care.
[5] K. Nakagome,et al. Relationship between airway inflammation and airflow limitation in elderly asthmatics , 2020, Asia Pacific allergy.
[6] N. Scichilone,et al. Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics , 2019, The World Allergy Organization journal.
[7] M. Pihlsgård,et al. Relative and absolute lung function change in a general population aged 60–102 years , 2019, European Respiratory Journal.
[8] C. Porsbjerg,et al. Co‐morbidities in severe asthma: Clinical impact and management , 2017, Respirology.
[9] A. Çilli,et al. Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[10] G. Rolla,et al. Effects of omalizumab in severe asthmatics across ages: A real life Italian experience. , 2016, Respiratory medicine.
[11] B. Rogala,et al. Asthma, COPD and comorbidities in elderly people , 2016, The Journal of asthma : official journal of the Association for the Care of Asthma.
[12] N. Scichilone,et al. Challenges in the pharmacological treatment of geriatric asthma , 2016, Expert review of clinical pharmacology.
[13] N. Scichilone,et al. Asthma in the elderly: a different disease? , 2016, Breathe.
[14] L. Boulet. Asthma in the elderly patient , 2016, Asthma Research and Practice.
[15] N. Scichilone,et al. The geriatric asthma: pitfalls and challenges , 2016, Asthma Research and Practice.
[16] J. Nadel,et al. Unraveling the Pathophysiology of the Asthma-COPD Overlap Syndrome: Unsuspected Mild Centrilobular Emphysema Is Responsible for Loss of Lung Elastic Recoil in Never Smokers With Asthma With Persistent Expiratory Airflow Limitation. , 2015, Chest.
[17] M. Kowalski,et al. Comorbidities in elderly patients with asthma: Association with control of the disease and concomitant treatment , 2015, Geriatrics & Gerontology International.
[18] N. Scichilone,et al. Safety Considerations of Inhaled Corticosteroids in the Elderly , 2014, Drugs & Aging.
[19] C. Franceschi,et al. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[20] E. Halm,et al. Depressive Symptoms, Low Adherence, and Poor Asthma Outcomes in the Elderly , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.
[21] M. King,et al. Asthma Prevalence among US Elderly by Age Groups: Age Still Matters , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.
[22] T. To,et al. Pulmonary function testing in the diagnosis of asthma: a population study. , 2012, Chest.
[23] W. Busse,et al. Omalizumab and the risk of malignancy: results from a pooled analysis. , 2012, The Journal of allergy and clinical immunology.
[24] B. Yawn,et al. Asthma in the elderly: Current understanding and future research needs—a report of a National Institute on Aging (NIA) workshop , 2011, Journal of Allergy and Clinical Immunology.
[25] L. Boulet,et al. Asthma-related comorbidities , 2011, Expert review of respiratory medicine.
[26] P. Austin,et al. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study. , 2011, Archives of internal medicine.
[27] A. Togias,et al. The impact of age on prevalence of positive skin prick tests and specific IgE tests. , 2011, Respiratory medicine.
[28] S. Suissa,et al. Inhaled corticosteroids and the risks of diabetes onset and progression. , 2010, The American journal of medicine.
[29] M. Miller,et al. Structural and physiological age-associated changes in aging lungs. , 2010, Seminars in respiratory and critical care medicine.
[30] K. Stoiber,et al. Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[31] Graziano Onder,et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. , 2010, Archives of internal medicine.
[32] Nicholas Moore,et al. Drug interactions between inhaled corticosteroids and enzymatic inhibitors , 2009, European Journal of Clinical Pharmacology.
[33] M. Weatherall,et al. Dose–response relationship for risk of non‐vertebral fracture with inhaled corticosteroids , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[34] Tonya S. King,et al. Aeroallergen sensitization correlates with PC(20) and exhaled nitric oxide in subjects with mild-to-moderate asthma. , 2008, The Journal of allergy and clinical immunology.
[35] F. Kianifard,et al. Response of Older Patients with IgE-Mediated Asthma to Omalizumab: A Pooled Analysis , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.
[36] R. Pistelli,et al. Validation of FEV6 in the elderly: correlates of performance and repeatability , 2007, Thorax.
[37] C. Wentworth,et al. Pooled clinical trial analysis of tiotropium safety. , 2006, Chest.
[38] A. Hansell,et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. , 2005, Chest.
[39] N. Scichilone,et al. Airway hyperresponsiveness in the elderly: prevalence and clinical implications , 2005, European Respiratory Journal.
[40] L. Boulet,et al. Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR , 2004, Allergy.
[41] J. Bousquet,et al. Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[42] F. Rengo,et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. , 2003, Chest.
[43] R. Norman,et al. Asthma in the elderly: cockroach sensitization and severity of airway obstruction in elderly nonsmokers. , 2002, Chest.
[44] N. Zamel,et al. Unsuspected loss of lung elastic recoil in chronic persistent asthma. , 2002, Chest.
[45] G. Bonsignore,et al. Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging. , 2001, Chest.
[46] M. Nieminen,et al. Increase of asthma in adults in northern Finland?– a report from the FinEsS study , 2001, Allergy.
[47] S. Suissa,et al. Association of inhaled corticosteroid use with cataract extraction in elderly patients. , 1998, JAMA.
[48] J D Best,et al. Differential changes of autonomic nervous system function with age in man. , 1983, The American journal of medicine.
[49] Sang-Heon Cho,et al. Classification and implementation of asthma phenotypes in elderly patients. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[50] J. Castro‐Rodriguez,et al. Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. , 2011, Chest.
[51] D. Postma,et al. Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men: the Normative Aging Study. , 1995, The European respiratory journal.